X-group (possible homology)

628 Fatty acid responsive transcription factor FadR, C-terminal domain

Ligands and drugs

329
Member domains
57
with ligand contacts (≤ 4 Å)
17.3% of members
45
with DrugDomain annotations
13.7% of members
26
with a DrugBank compound
7.9% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

13
Proteins with classified ligands
6
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Homogeneous metal compounds116.31.75×q = 0.02
Lipids and lipid-like molecules31.42.10×not tested
Homogeneous non-metal compounds32.81.09×not tested
Organic acids and derivatives12.00.50×not tested
Organic oxygen compounds12.60.39×not tested
Nucleosides, nucleotides, and analogues13.50.28×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB01992COACoenzyme A1
DB04072MICAlpha-Methylisocitric Acid1
DB04265SLBN-acetyl-beta-neuraminic acid1
DB08231MYRMyristic acid1

Most frequently bound compounds

PDB ligandNameDomains in contact
ZNmetalZINC ION37
CLCHLORIDE ION4
NImetalNICKEL (II) ION4
2HG(2R)-2-hydroxypentanedioic acid2
3VVS-{(3R,5R,9R)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14-dioxo-2,4,6-trioxa-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaheptadecan-17-yl} (9Z)-octadec-9-enethioate (non-preferred name)2
AUmetalGOLD ION2
P4Kpolyethylene glycol2
PKZPalmitoyl-CoA2
BRBROMIDE ION1
COACOENZYME A1
MICALPHA-METHYLISOCITRIC ACID1
MYRMYRISTIC ACID1
SLBN-acetyl-beta-neuraminic acid1